Top-image-about-us

About us

websote

Biotec Pharmacon ASA is a biotechnology company developing, producing and marketing immune modulating beta-glucans and novel recombinant enzymes. The Company is organized into two business areas, each managed as a separate operating unit.

For more information about Biotec Pharmacon 
go to biotec.no

BiotecBetaglucans-logo-RGB-300dpi

Biotec BetaGlucans is a subsidiary of Biotec Pharmacon and focus on the use of immunomodulatory beta-1,3/1,6-glucan derivered from yeast in different application areas: including wound care, cancer adjuvant, animal health and human nutrition.

Grafik_stamtrae

Soluble BetaGlucans management

Rolf Engstad

Rolf Engstad

CSO

Rolf (born 1959) holds a M.Sc. in biology and a Ph.D in biochemistry from the University of Tromsø, where he was employed as researcher from 1988 to 1998.

Finn Ketler

Finn Ketler

Vice President, Wound Care

Finn (born 1962) has a M.Sc. degree from Aarhus Business School. Finn has a long and extensive background within medical devices and wound care.

Ingrid Skjæveland

Ingrid Skjæveland

Scientific Product manager Woulgan

Ingrid (born 1977) holds a Civil Engineer in Biotechnology and a PhD in Immunology from the University of Tromsø.

Hubertus Ruthman

Hubertus Ruthman

Commercial Manager Germany

Hubertus holds a Master of Business Administration and has many years of experience in national and international marketing and sales roles in the medical device area.